- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
November 14, 2019
Stem cell transplants continue to yield positive results in patients with multiple sclerosis and other autoimmune diseases, with the latest milestone emerging from Northwestern Medicine and Mayo Clinic.
October 24, 2019
Unfortunately, an established test for ovarian cancer, the CA125 test, is limited in its power and not recommended for general screening. Researchers in Ireland have come up with a potential improvement, a blood test that may be able to detect ovarian cancer one to two years earlier than current approaches.
October 17, 2019
One dose of one treatment to defeat multiple types of cancers? That’s the intriguing, if far-off, possibility suggested by a new development by UCLA scientists working with mice. The scientists focused on boosting production of “killer” immune cells that, though powerful, aren’t naturally prevalent enough in humans to make much of a difference for cancer patients.
October 1, 2019
October officially kicks off Breast Cancer Awareness Month. Breast cancer is the most common cancer in women with about 245,000 new cases and 41,000 deaths each year.
September 19, 2019
Scientists have studied the human brain for millennia, but only recently have they been cultivating brains – well, “minibrains” – from scratch: Researchers at University of California San Diego have programmed human stem cells to grow the pea-sized organoids of brain tissue in the lab.
August 8, 2019
Alzheimer’s disease remains stubbornly resistant to cures, though some progress is being made, especially on the diagnostic side. “We don’t have a lot of positive news these days,” Martin Tolar, CEO of Alzheon, told STAT for a story on last month’s Alzheimer’s Association International Conference in Los Angeles. “But I do believe there’s a lot […]
August 1, 2019
A human biospecimen is a potential font of biological data—data that when aggregated in enormous volumes and crunched by artificial intelligence drives the development of precision medicine. By analyzing genetic profiles of patients and tumors, and by matching mutations to targeted drugs, precision medicine is halting or reversing cancer…in a small fraction of cases.
July 25, 2019
As medical researchers steadily amass knowledge of the human genome, there’s a stubborn blind spot: Most genomic research arises from subjects of white European descent. In 2,500 recently published human genomics papers reviewed in one recent study, only 19% of the participants were of non-European ancestry. The diversity deficit is a problem: At stake is […]
July 11, 2019
Biofluids – including blood, plasma, saliva, urine and even cheek swabs – can tell us a lot about a person’s health, which is why patients are routinely asked to provide these samples in the lab for testing. With a small amount of blood, for example, complex testing and screening of its chemistry, enzymes, lipoproteins and […]